Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 284, Issue 3 47-3, 2003, Pages

  Hung, Daniel Y ^a   Burczynski, Frank J ^b   Chang, Ping ^a   Lewis, Andrew ^c   Masci, Paul P ^a   Siebert, Gerhard A ^a   Anissimov, Yuri G ^a   Roberts, Michael S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Clofibrate; Cytoplasmic diffusion constant; Hepatic extraction ratio; Multiple indicator dilution; Pregnancy

Indexed keywords

ALBUMIN; BINDING PROTEIN; FATTY ACID BINDING PROTEIN; GLUTATHIONE TRANSFERASE; PALMITIC ACID; PALMITIC ACID DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; FEMALE; LIVER CLEARANCE; LIVER PERFUSION; MALE; METABOLIC CLEARANCE RATE; METABOLITE; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; RAT;

EID: 0037369482     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00328.2002     Document Type: Article

References (45)

1. Adams J. Heavy metal intensification of DAB-based HRP reaction product (Abstract). J Histochem Cytochem 29: 776, 1981.
2. Alin P, Danielson UH, and Mannervik B. 4-Hydroxyalk-2-enals are substrates for glutathione transferase. FEBS Lett 179: 267-270, 1985.
3. Bass L, Roberts M, and Robinson P. On the relation between extended forms of the sinusoidal perfusion and of the convectiondispersion models of hepatic elimination. J Theor Biol 126: 457-482, 1987.
4. Bass NM. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int Rev Cytol 3: 143-184, 1988.
5. Bass NM, Manning JA, Ockner RK, Gordon JI, Seetharam S, and Alpers DH. Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine. Influences of sex difference and of clofibrate. J Biol Chem 260: 1432-1436, 1985.
6. Besnard P, Foucaud L, Mallordy A, Berges C, Kaikaus RM, Bernard A, Bass NM, and Carlier H. Expression of fatty acid binding protein in the liver during pregnancy and lactation in the rat. Biochim Biophys Acta 1258: 153-158, 1995.
7. Burczynski FJ, Pond SM, Davis CK, Johnson LP, and Weisiger RA. Calibration of albumin-fatty acid binding constants measured by heptane-water partition. Am J Physiol Gastrointest Liver Physiol 265: G555-G563, 1993.
8. Burczynski FJ, Zhang MN, Pavletic P, and Wang GQ. Role of fatty acid binding protein on hepatic palmitate uptake. Can J Physiol Pharmacol 75: 1350-1355, 1997.
9. Charlton M, Sreekumar R, Rasmussen D, Lindor K, and Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 35: 898-904, 2002.
10. Cheung K, Hickman PE, Potter JM, Walker NI, Jericho M, Haslam R, and Roberts MS. An optimized model for rat liver perfusion studies. J Surg Res 66: 81-89, 1996.
11. Elias N, Patterson WB, and Schonfeld G. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol 19: 2714-2721, 1999.
12. Elmadhoun BM, Wang GQ, Kirshenbaum LA, and Burczynski FJ. Palmitate uptake by neonatal rat myocytes and hepatocytes. Role of extracellular protein. Eur J Biochem 268: 3145-3153, 2001.
13. 3H]palmitate to BSA. Am J Physiol Gastrointest Liver Physiol 275: G638-G644, 1998.
14. Evans AM, Hussein Z, and Rowland M. Influence of albumin on the distribution and elimination kinetics of diclofenac in the isolated perfused rat liver: analysis by the impulse-response technique and the dispersion model. J Pharm Sci 82: 421-428, 1993.
15. Evans JH, Brocklebank JT, Bowmer CJ, and Ng PC. Pharmacokinetics of recombinant human erythropoietin in children with renal failure. Nephrol Dial Transplant 6: 709-714, 1991.
16. Goresky CA, Bach GC, and Nadeau BE. On the uptake of materials by the intact liver. The transport and net removal of galactose. J Clin Invest 52: 991-1009, 1973.
17. Goresky CA, Daly DS, Mishkin S, and Arias IM. Uptake of labeled palmitate by the intact liver: role of intracellular binding sites. Am J Physiol Endocrinol Metab Gastrointest Physiol 234: E542-E553, 1978.
18. Goresky CA, Stremmel W, Rose CP, Guirguis S, Schwab AJ, Diede HE, and Ibrahim E. The capillary transport system for free fatty acids in the heart. Circ Res 74: 1015-1026, 1994.
19. Gustafsson JE and Uzqueda HR. Urinary albumin determination by the immediate bromcresol green method. Clin Chim Acta 90: 241-248, 1978.
20. Hung DY, Chang P, Cheung K, McWhinney B, Masci PP, Weiss M, and Roberts MS. Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug. J Pharmacol Exp Ther 301: 1079-1087, 2002.
21. Hung DY, Chang P, Weiss M, and Roberts MS. Structurehepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process. J Pharmacol Exp Ther 297: 780-789, 2001.
22. Kushlan M, Gollan J, MLW, and Ockner R. Sex differences in hepatic uptake of long chain fatty acids in single-pass perfused liver. J Lipid Res 22: 431-436, 1981.
23. Lowry O, Rosebrough N, Farr A, and Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
24. Luxon BA. Inhibition of binding to fatty acid binding protein reduces the intracellular transport of fatty acids. Am J Physiol Gastrointest Liver Physiol 271: G113-G120, 1996.
25. Luxon BA, Holly DC, Milliano MT, and Weisiger RA. Sex differences in multiple steps in hepatic transport of palmitate support a balanced uptake mechanism. Am J Physiol Gastrointest Liver Physiol 274: G52-G61, 1998.
26. Luxon BA, Milliano MT, and Weisiger RA. Induction of hepatic cytosolic fatty acid binding protein with clofibrate accelerates both membrane and cytoplasmic transport of palmitate. Biochim Biophys Acta 1487: 309-318, 2000.
27. Luxon BA and Weisiger RA. A new method for quantitating intracellular transport: application to the thyroid hormone 3,5,3′-triiodothyronine. Am J Physiol Gastrointest Liver Physiol 263: G733-G741, 1992.
28. Matsubara T, Koike M, Touchi A, Tochino Y, and Sugeno K. Quantitative determination of cytochrome P-450 in rat liver homogenate. Anal Biochem 75: 596-603, 1976.
29. Mellick GD and Roberts MS. Structure-hepatic disposition relationships for phenolic compounds. Toxicol Appl Pharmacol 158: 50-60, 1999.
30. Motojima K. Differential effects of PPARα activators on induction of ectopic expression of tissue-specific fatty acid binding protein genes in the mouse liver. Int J Biochem Cell Biol 32: 1085-1092, 2000.
31. Pond SM, Gordon RA, Wu ZY, Weisiger RA, and Bass L. Effects of gender and pregnancy on hepatocellular uptake of palmitic acid: facilitation by albumin. Am J Physiol Gastrointest Liver Physiol 267: G656-G662, 1994.
32. Purves RD. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). J Pharmacokinet Biopharm 20: 211-226, 1992.
33. Reddy JK and Mannaerts GP. Peroxisomal lipid metabolism. Annu Rev Nutr 14: 343-370, 1994.
34. Roberts MS, Donaldson JD, and Rowland M. Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination. J Pharmacokinet Biopharm 16: 41-83, 1988.
35. Saunders G. The art of solid-phase enzyme immunoassay including selected protocols. In: Immunoassays in a Clinical Laboratory. New York: Liss, 1979, p. 99-118.
36. Schwab AJ and Pang KS. The multiple indicator-dilution method for the study of enzyme heterogeneity in liver: theoretical basis. Drug Metab Dispos 27: 746-755, 1999.
37. Simpson AE. The cytochrome P450 4 (CYP4) family. Gen Pharmacol 28: 351-359, 1997.
38. Soler-Argilaga C and Heimberg M. Comparison of metabolism of free fatty acid by isolated perfused livers from male and female rats. J Lipid Res 17: 605-615, 1976.
39. Sorrentino D, Stump DD, Van Ness K, Simard A, Schwab AJ, Zhou SL, Goresky CA, and Berk PD. Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate. Am J Physiol Gastrointest Liver Physiol 270: G385-G392, 1996.
40. Takahashi K, Odani S, and Ono T. Isolation and characterization of the three fractions (DE-I, DE-II and DE-III) of rat-liver Z-protein and the complete primary structure of DE-II. Eur J Biochem 136: 589-601, 1983.
41. Weisiger RA. Saturable stimulation of fatty acid transport through model cytoplasm by soluble binding protein. Am J Physiol Gastrointest Liver Physiol 277: G109-G119, 1999.
42. Weisiger RA and Zucker SD. Transfer of fatty acids between intracellular membranes: roles of soluble binding proteins, distance, and time. Am J Physiol Gastrointest Liver Physiol 282: G105-G115, 2002.
43. Weiss M, Kuhlmann O, Hung DY, and Roberts MS. Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver. Br J Pharmacol 130: 1331-1338, 2000.
44. Weiss M and Roberts MS. Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb. J Pharmacokinet Biopharm 24: 173-196, 1996.
45. Weiss M, Stedtler C, and Roberts MS. On the validity of the dispersion model of hepatic drug elimination when intravascular transit time densities are long-tailed. Bull Math Biol 59: 911-929, 1997.